The effects of retinoic acid analogue -phytol (precursor of retinoic X receptors ligand), TTNPB (retinoic acid receptor agonist) and seocalcitol (EB1089, analogue of vitamin D3) in mammary tumours of Sprague-Dawley rats induced with 1-methyl-1-nitrosourea (MNU) were investigated. Treatment with phytol, TTNPB and seocalcitol may have some protective and therapeutical effects on malignant processes. Treatment with these components in combination of TTNPB and phytol or seocalcitol and phytol inhibited progression of MNU-induced tumours of the rat mammary gland, and also induced decrease of tumour burden and volume in comparison with treated control group. Treatment of rats with the above compounds had no effect on malignity and invasiveness of carcinomas.
Introduction
Breast cancer continues to be the second leading cause of cancer mortality in women. Statistics suggest that while focus on treatment should continue, chemopreventive approaches should also be pursued. Retinoids as well as vitamin D 3 and its analogue seocalcitol have shown some chemopreventive properties in chemically induced breast cancer (Macejová et al. 2001; Colston et al. 2003; Ondková 2006; Brtko 2007) . Retinoids, rexinoids and their biologically active derivatives are involved in a complex arrangement of physiological and developmental responses in many tissues of higher vertebrates. Both retinoids and rexinoids are either natural or synthetic compounds related to retinoic acids (RAs) that act through interaction with two basic types of nuclear receptors belonging to the nuclear receptor superfamily: all-trans-RA receptors (RARα, RARβ and RARγ) and retinoid X receptors (RXRα, RXRβ and RXRγ) as retinoid-inducible transcription factors (Brtko 2007) . Previous studies have demonstrated that naturally occurring retinoids, such as 9cis retinoic acid (9cRA), can induce either differentiation or cell death in breast cancer cells in a cellcontext dependent manner (Jiménez-Lara et al. 2010) and can prevent breast cancer in animal models (Anzano et al. 1994) , but with apparent toxicity (Miller et al. 1996) . Retinoids are vitamin A analogues with vitamin A activity. These analogues function in regulating cell growth, differentiation, and apoptosis. Alltrans-RA also induces mammary gland lumen formation in a dose-and time-dependent manner (Montesano & Soulié 2002) . Retinoids have exhibited some chemopreventive properties in chemically induced breast cancer in laboratory rodents (reviewed in Jiménez-Lara et al. 2010) . Phytol (P) is a derivative of the chlorophyll molecule. Phytanic acid, for which phytol is a precursor molecule, is a ligand for RXRα. A structural relation is apparent when comparing to 9cRA molecule. Interestingly, although the structural resemblance of phytanic acid is the same to all-trans-RA and 9cRA, phytanic acid is not able to bind RARs (Lemotte et al. 1996) . (E)-4- [2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl )-1-propen yl]-benzoic acid (TTNPB or T) known also as "arotinoid", derived from "aromatic retinoid", which acts as a selective RAR agonist, represents a powerful tool in both nuclear retinoid receptor and cancer treatment research (Strickland et al. 1983; Wu et al. 2002) . Wu et al. (2006) showed that an RXRselective retinoid LGD1069 prevented tumour development in animal models of cancer with reduced toxicity as compared to RAR-selective retinoid TTNPB.
Under various experimental conditions, combining retinoid treatment with other modifiers of growth enhances its chemopreventive activity; for example, retinoid plus hormonal modulation can provide better protection against mammary cancer than either treatment alone (Moon 1989; Koay et al. 2010) . It has been shown that the combined treatment of MCF-7 human breast cancer cells with TTNPB with another RXRselective retinoid (LGD100268) caused a dramatic stimulation of the aromatase activity (Yanase et al. 2001 ). These observations suggest that the RAR:RXR heterodimer nuclear receptor systems may be another important modulator of estrogen production in human breast cancer cells.
It has been shown above that TTNPB that binds specifically to RAR but not to RXR receptors, is a potent inducer of lumen formation via activation of RARα receptor. By contrast, RXR-selective ligands, including the naturally occurring compound phytanic acid (Kitareevan et al. 1996) , are unable to induce lumen formation in mammary gland.
Synthetic analogues of vitamin D 3 and retinoids combinations represent a perspective in the therapy of tumours in some organs including carcinomas of breast (Koshizuka et al. 1999) . Although 1,25dihydroxyvitamin D 3 is a potent cell-differentiating agent, its use in cancer prevention or therapy is precluded because it induces hypercalcaemia. Some synthetic analogues of vitamin D 3 can inhibit tumour progression in animal models of breast cancer without inducing hypercalcaemia. One of them, seocalcitol (Seo), has been shown to be effective in causing regression of 1-methyl-1-nitrosourea (MNU)-induced rat mammary tumours (Colston et al. 2003) .
Mammary tumours in rats are very close to human ones (in humans and rats, they are predominantly ductal); their induction by MNU in virgin female rats is one of the most frequently used animal models for the investigation of breast carcinogenesis and mammary tumours therapy. MNU-induced mammary carcinomas are aggressive and locally invasive, and they are capable to metastasize (Thompson & Adlakha 1991) . Endocrine status of MNU-induced rat mammary carcinomas appears similar to human breast cancer (Russo et al. 1979) . Prolactin and estrogen receptors are present in some of the MNU-induced carcinomas (Rose et al. 1980) . Prolactin is also important in the early developmental stages of MNU-induced rat mammary gland tumourigenesis. Using cancer-causing chemicals to induce mammary gland cancer in rats has been a model for understanding the breast cancer development. With their short lifespan the results of testing can be achieved relatively quickly (Welsch 1985; Thompson et al. 1995) .
The aim of the present study was to investigate the therapeutical effect of administration of RXR-selective ligand phytol in combination with RAR-selective ligand TTNBP or precursor of vitamid D 3 receptor ligand seocalcitol (EB1089, analogue of vitamin D 3 ) on histological characteristics of MNU-induced mammary tumours of female Sprague-Dawley rats.
Material and methods
Female Sprague-Dawley rats were obtained from Charles-River farm. Rats were housed 4-5 per cage and maintained at 12 h light-dark cycle. They were fed standard laboratory diet and with access to water ad libitum (Líška et al. 2000) . Rats were administered intraperitoneally with 50 mg/kg body weight MNU at the 46 th and 52 th day of age alternately in the left and the right abdominal part.
Intact control animals and also control animals treated with MNU were administered propylene glycol according their body weight and protocol scheme of application in experimental groups. TTNPB (Sigma-Aldrich, Germany; 0.7 µg/kg in propylene glycol) and phytol (Sigma-Aldrich, Germany; 0.5 µg/kg) in group T and P were administered after tumour detection (approximately on the 100 th day of life) -three-times per week. Combinations of phytol and TTNPB or phytol and seocalcitol (Leo Pharma, Denmark; 7 µg/kg per week) were administered in groups T+P and Seo+P after tumour detection until the end of experiment (Fig. 1) . Animals were regularly palpated on weekly basis. The experiment was finished on 181 st day of age. All animals were euthanized by decapitation and their skin was examined through translucent light. Dissected animals were photographed to provide record of the location of lesions. Tumours were removed, measured and weighed. After excidation tumours were fixed in 10% buffered formalin and processed for histopathological evaluation. Paraffin sections of the excised tissues were stained with hematoxylin and eosin and evaluated in light microscope with fluorescence (NICON ECLIPSE 80i, The Netherlands). Principles of laboratory animal care and all procedures were approved by the Animal Care Committee of the Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia. The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health.
Results and discussion
Combination of TTNPB and phytol or seocalcitol and phytol in rats that underwent the MNU-treatment caused a significant decrease of body weight in comparison with intact control animals (both p < 0.05). However, we have already shown that both preventive and therapeutical administration of seocalcitol alone had no effect on body weight of animals or liver/spleen:body weight ratios (Macejová et al. 2009 ). Significant diminution of body weight in comparison with MNU-treated animals was observed only after treatment with combination of TTNPB and phytol (data not shown). This observation may indicate toxicity of this combination but it did not affect liver/spleen:body weight ratios. No significant decrease of body weight was detected in other experimental groups, comprising treatment with TTNPB or phytol.
The combinations TTNPB+P and Seo+P decreased, but not significantly, the number, weight and volume of tumours when compared with the control MNU group. However, combination of TTNPB+P significantly reduced number of tumours and tumour burden when compared to MNU group of animals treated with TTNPB alone (T group) (p < 0.05). Decrease of body weight in the groups TTNPB+P and Seo+P could also be linked with decreased number, weight and volume of mammary gland tumours. Combinations of phytol with TTNPB or seocalcitol inhibited progression of MNU-induced mammary tumours in rats (Fig. 2) .
Tumours observed in autopsy were encapsulated and mostly of solid consistence. Various combinations of papillary, cribriform or comedo patterns of ductal carcinomas were observed in microscope. Russo et al. (1990) described papillary carcinomas as the most typical and frequent of the MNU-induced mammary tumours. In our experiment, papillary carcinomas in uniform pattern were observed only in one case, but they were the most frequent carcinomas in combination with cribriform pattern. Simple patterns of above-mentioned carcinomas appeared rarely. Stromal response was demonstrated by fibrosis with mononuclear infiltration.
Invasiveness was evaluated also in epifluorescence to evaluate the basement membrane of glandular parenchyma . Proportions of carcinoma patterns and invasiveness in treated groups are given in Table 1 .
Invasiveness observed in all groups ranged from 80% to 90%. No one of the compounds used in described experimental groups was shown to reduce the number of invasive tumours. The highest invasiveness not significant in comparison with the MNU group was observed after treatment with phytol. The tissue invasion was only local (Líška et al. 2003) . Metastases were not observed in distant sites. McCormick et al. (1981) in a lifetime dose response study after MNU concluded that one of the advantages in the MNU model should be spreading of metastases to distant sites. Some authors described adenocarcinomas with various degrees of differentiation, but no evidence for metastasis after MNU administration (Rose et al. 1980; Takahashi et al. 1995) . Other authors mentioned that metastases from even the most anaplastic tumours are at low frequency (Russo et al. 1990 ). We started with MNU administration after established ovarian function in animals. MNU-induced mammary tumours appeared to be predominantly estrogendependent. Greater prevalence of the hormone independent phenotype would occur in mammary tumours of rats initiated with MNU prior to sexual maturation.
It is postulated that retinoids can act postnatally as stabilizers of epithelial tissue architecture, thereby preventing tumourigenesis. The redifferentiating effects were not confirmed in this experiment. Carcinomas in our experiment in all groups were mostly invasive. However, metastases were not observed in other sites of organism. Russo et al. (1990) reported that metastases can be observed in prolonged study for two or three years.
The aromatic retinoid TTNPB is one of the most potent inducers of differentiation in F9 cells (Strickland et al. 1983) . TTNPB is also 1000-times more active than all-trans-RA in suppressing skin papillomas in mice (Loeliger et al. 1980) . Wu et al. (2002) found out that TTNPB-treated transgenic mice showed a delayed median time to tumour development, but no changes were seen in tumour multiplicity. However, toxicity (skin erythema, hair loss) was seen in all of the mice treated with TTNPB. These lesions were not observed in rats used in our experiment. Also liver burden/body weight proportion did not differ in experimental group of animals in our experiment when compared to control animals.
It has been shown that retinoids are most effective when administered shortly after the carcinogen treatment (Moon 1989) . In our experiment, the treatment with the selected biologically active compounds was given after the observation of the first tumour (approximately on the 100 th day of life). However, administration of TTNPB resulted in induction of tumour incidence and progression. This observation could indicate that TTNPB is effective during early stages of carcinogenesis, but in advanced mammary gland cancer it could act as a "tumour progression enhancer". This enhancement of tumour growth was reduced by concurrent administration of phytol. We have observed a slight inhibition of tumour progression caused by administration phytol alone, as well. This inhibition was emphasized by concurrent administration of seocalcitol.
In conclusion, the combinations phytol with TTNPB or seocalcitol inhibited progression of MNUinduced mammary tumours of the rat breast and also inhibited increase of tumour burden and volume in comparison with MNU-treated control group. There was observed no redifferentiating effect found after the treatment with above-mentioned compounds. None of the compounds either alone or in combination reduced malignity or number of invasive tumours. Further work on the effect of phytol, TTNPB or seocalcitol on selected hormone nuclear receptors status in rat mammary gland tumours is necessary. The study of the relationship between mammary tumour growth suppression and actions mediated via nuclear hormone receptor pathways may provide us with significant information about the regulatory programs within cells.
